Five industry associations representing pharmaceutical, biotech and medical technologies industries operating in Europe (COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe) have come together to work on a Strategic Agenda for the proposed European Health Innovation Public-Private Partnership (PPP) under Horizon Europe.

As the Strategic Research Agenda is still under development, new examples in three areas (obesity, asthma and breast cancer) illustrate how only a cross-sectoral partnership bringing together stakeholders along the patient's journey can make significant progress towards addressing unmet health needs. These How will the combination of genomics, proteomics, metabolomics, and biomarkers research create a better understanding of obesity? How can we enhance the use of ground-breaking biologics and smart inhalers to faster diagnose patients with steroid-resistant asthma? How can we integrate and assess new and promising therapies for breast cancer care?

You can access the case studies here